Clinical profile of early-onset Alzheimer's disease in Peru: case series from a neurological care center.

Rev Peru Med Exp Salud Publica

Centro Básico de Investigación en Demencias y Enfermedades Desmielinizantes del Sistema Nervioso, Instituto Nacional de Ciencias Neurológicas, Lima, Perú.

Published: August 2025


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Background: Motivation for the study. To describe the clinical characteristics of early-onset Alzheimer's disease (EOAD) and compare them according to gender. This condition is considered a rare disease, whose manifestations are still poorly understood. Main findings. The most common clinical presentation of EOAD is the amnestic variant, which mainly affects episodic memory and executive function and is often accompanied by neuropsychiatric symptoms such as depression and irritability. Women tend to have more impairments in calculus, constructive apraxia, and visuospatial functions than men. Implications for public health. By identifying the clinical characteristics of EOAD, healthcare professionals can recognize patients early on. Furthermore, it is essential to broaden the concept of dementia, avoiding limiting it exclusively to the population over 65 years of age.

Background: Early-onset Alzheimer's disease (EOAD) accounts for between 5 and 10% of all cases of Alzheimer's disease and is a rare and devastating form of the disease. This retrospective study analyzed the medical records of patients diagnosed with EOAD between 2022 and 2023 at a tertiary neurological center in Lima, Peru. Of 547 cases of dementia, 60 met the criteria for EOAD. Most were women (73.3%), and 71% had more than six years of education. The mean MMSE score was 11.92 ± 7.5, and the mean CDR score was 2, indicating severe cognitive impairment and moderate dementia. The amnestic variant was the most common clinical form, highlighting the involvement of episodic memory and executive function. The most common psychological and behavioral symptoms were depression and irritability. Atypical features such as myoclonus (5%) and epilepsy (10%) were also identified. These findings highlight the importance of healthcare professionals recognizing dementia in young adults at an early stage and offering comprehensive management to improve the quality of life of patients and their families.

Background: Motivation for the study. To describe the clinical characteristics of early-onset Alzheimer's disease (EOAD) and compare them according to gender. This condition is considered a rare disease, whose manifestations are still poorly understood. Main findings. The most common clinical presentation of EOAD is the amnestic variant, which mainly affects episodic memory and executive function and is often accompanied by neuropsychiatric symptoms such as depression and irritability. Women tend to have more impairments in calculus, constructive apraxia, and visuospatial functions than men. Implications for public health. By identifying the clinical characteristics of EOAD, healthcare professionals can recognize patients early on. Furthermore, it is essential to broaden the concept of dementia, avoiding limiting it exclusively to the population over 65 years of age.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12377887PMC
http://dx.doi.org/10.17843/rpmesp.2025.422.14413DOI Listing

Publication Analysis

Top Keywords

alzheimer's disease
20
early-onset alzheimer's
16
clinical characteristics
16
disease eoad
12
common clinical
12
amnestic variant
12
episodic memory
12
memory executive
12
executive function
12
symptoms depression
12

Similar Publications

Background: Early identification of pathological α-synuclein deposition (αSynD) may improve understanding of Lewy body disorder (LBD) progression and enable timely disease-modifying treatments.

Objectives: We investigated αSynD using a seed amplification assay and assessed prodromal LBD symptoms in individuals with idiopathic olfactory dysfunction (iOD).

Methods: In this cross-sectional, case-control study, we included iOD participants and normosmic healthy controls (HC) aged 55 to 75 years without diagnoses of dementia with Lewy bodies, Parkinson's disease (PD), or other major neurological disorders.

View Article and Find Full Text PDF

Neurodegenerative disorders (NDD) i.e., dementia of the Alzheimer's type, Parkinson's disease, Huntington's disease, and amyotrophic lateral sclerosis are a rising worldwide epidemic driven by aging populations and characterized by progressive neuronal impairment.

View Article and Find Full Text PDF

Peripheral Inflammation Is Associated With Greater Neuronal Injury and Lower Episodic Memory Among Late Middle-Aged Adults.

J Neurochem

September 2025

Division of Neurogeriatrics, Center for Alzheimer Research, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden.

Elucidating the earliest biological mechanisms underlying Alzheimer's disease (AD) is critical for advancing early detection strategies. While amyloid-β (Aβ) and tau pathologies have been central to preclinical AD research, the roles of peripheral biological processes in disease initiation remain underexplored. We investigated patterns of F-MK6240 tau positron emission tomography (PET) and peripheral inflammation across stages defined by Aβ burden and neuronal injury in n = 132 (64.

View Article and Find Full Text PDF

Antibody Therapies for Alzheimer's Disease: A New Strategy for Targeted Therapy and Blood-Brain Barrier Delivery.

ACS Chem Neurosci

September 2025

Institute of Cell Engineering, School of Medicine, Johns Hopkins University, Baltimore, Maryland 21215, United States.

Alzheimer's disease (AD) is a neurodegenerative disease characterized by progressive cognitive impairment and neuronal loss, with pathological hallmarks including Aβ plaque deposition and tau tangles. At present, the early diagnosis and treatment of AD still face great challenges, such as limited diagnostic methods, difficulty in blood-brain barrier (BBB) penetration, complex disease mechanisms, and lack of highly effective targeted therapies. Antibody drugs have shown broad prospects in the field of AD due to their high specificity, engineering and multifunctional therapeutic potential, include targeted Aβ clearance, tau pathological regulation, imaging probes, and blood biomarkers.

View Article and Find Full Text PDF

Network Pharmacology of miR-146a-5p as a Potential Anti-Inflammatory Agent in Preventing Alzheimer's Disease.

Curr Alzheimer Res

September 2025

School of Biosciences, Faculty of Health and Medical Sciences, Taylor's University, 47500 Subang Jaya, Selangor, Malaysia.

Introduction: Alzheimer's disease is expressed as chronic neuroinflammation in the brain, which results in neuronal dysfunction, aberrant protein folding, and declining cognitive abilities. miR-146a-5p is a potent anti-inflammatory agent that can be used to treat several inflammatory diseases, as well as promote wound healing. Our research aimed to utilize network pharmacology to elucidate the therapeutic potential of miR-146a-5p in treating Alzheimer's disease using a biocomputational approach.

View Article and Find Full Text PDF